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Abstract
Background and Aims: Galectin-3 [Gal-3] is an endogenous lectin with a broad spectrum of 
immunoregulatory effects: it plays an important role in autoimmune/inflammatory and malignant 
diseases, but the precise role of Gal-3 in pathogenesis of ulcerative colitis is still unknown.
Methods: We used a model of dextran sulphate sodium [DSS]-induced acute colitis. The role of Gal-3 
in pathogenesis of this disease was tested by evaluating disease development in Gal-3 deficient mice 
and administration of Gal-3 inhibitor. Disease was monitored by clinical, histological, histochemical, and 
immunophenotypic investigations. Adoptive transfer was used to detect cellular events in pathogenesis.
Results: Genetic deletion or pharmacological inhibition of Gal-3 significantly attenuate DSS-induced 
colitis. Gal-3 deletion suppresses production of pro-inflammatory cytokines in colonic macrophages 
and favours their alternative activation, as well as significantly reducing activation of NOD-like receptor 
family, pyrin domain containing 3 [NLRP3] inflammasome in macrophages. Peritoneal macrophages 
isolated from untreated Gal-3-/- mice and treated in vitro with bacterial lipopolysaccharide or DSS 
produce lower amounts of tumour necrosis factor alpha [TNF-α] and interleukin beta [IL-1β] when 
compared with wild type [WT] cells. Genetic deletion of Gal-3 did not directly affect total neutrophils, 
inflammatory dendritic cells [DCs] or natural killer [NK] T cells. However, the total number of CD11c+ 
CD80+ DCs which produce pro-inflammatory cytokines, as well as TNF-α and IL-1β producing CD45+ 
CD11c- Ly6G+ neutrophils were significantly lower in colons of Gal-3-/- DSS-treated mice. Adoptive 
transfer of WT macrophages significantly enhanced the severity of disease in Gal-3-/- mice.
Conclusions: Gal-3 expression promotes acute DSS-induced colitis and plays an important 
pro-inflammatory role in the induction phase of colitis by promoting the activation of NLRP3 
inflammasome and production of IL-1β in macrophages.
Keywords:  Gal-3; DSS colitis; NLRP3
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1. Introduction
Galectin-3 [Gal-3] is an endogenous lectin with a broad spectrum 
of immunoregulatory effects: it plays an important disease-exac-
erbating role in autoimmune/inflammatory and malignant dis-
eases,1,2,3,4,5,6 but has protective role in obesity-induced inflammation 
and type 2 diabetes.7 Recently, clinical studies suggested a role for 
Gal-3 in ulcerative colitis [UC].8,9,10 Serum concentrations of Gal-3 
were significantly increased in specimens of patients with active 
and remission-stage UC.8,9,10 In UC patients, Gal-3 was produced 
by monocytes9 and expressed on CD68+ colon-infiltrating mac-
rophages.10 However, the precise role of Gal-3 in pathogenesis of UC 
is still unknown.
Because of the high degree of uniformity and reproducibility, as 
well as some similarities to human colitis, dextran sulphate sodium 
[DSS]-induced colitis has been used to elucidate molecular and cellu-
lar pathways involved in pathogenesis of acute colitis.11 DSS-induced 
colitis has been considered to be driven by macrophages which pro-
duce inflammatory cytokines and chemokines, cause tissue damage, 
and induce migration of neutrophils, dendritic cells [DCs], natural 
killer [NK] and NK T cells, mast cells and eosinophils in the colon.12 
Effector cells of acquired immunity are not involved in acute colitis, 
as disease occurs in T and B cell-deficient mice.13
Since Gal-3 is involved in migration and function of innate immune 
cells,14,15,16 we used DSS-induced colitis to evaluate the role of Gal-3 
in the pathogenesis of acute colitis. Here we provide the first evidence 
that genetic deletion or pharmacological inhibition of Gal-3 leads to a 
marked attenuation of DSS-induced colitis due to reduced activation 
of NOD-like receptor family, pyrin domain containing 3 [NLRP3] 
inflammasome and attenuated production of interleukin beta [IL-1β] 
in macrophages. Our data indicate that Gal-3 plays an important pro-
inflammatory role in DSS-induced colitis and may be a potential target 
for therapeutic intervention in intestinal inflammatory disorders.
2. Materials and Methods
2.1. Patients
Patients with clinically and histologically proven diagnosis of UC 
[n = 10] and non-UC controls [n = 10] [patients with negative histo-
logical findings, who underwent colonoscopy because of colon can-
cer screening or abdominal problems] were included in this study.
In each individual case, the diagnosis and assessment of the sever-
ity of UC was confirmed by standard colonoscopy, histological crite-
ria, and disease activity, as previously described.8,9,10
All patients gave their informed consent for blood and tissue 
analysis, and the study has been approved by the local ethics com-
mittee of Clinical Center Kragujevac, Faculty of Medical Sciences, 
University of Kragujevac. Patients were under continuous medical 
supervision at the Clinical Center Kragujevac, Faculty of Medical 
Sciences University of Kragujevac.
2.2. Expression of Gal-3 on colon infiltrating 
macrophages and its correlation with expression of 
inflammatory cytokines
Biopsy samples were obtained by colonoscopy from patients with 
acute UC and from non-UC controls. The expression of Gal-3, CD68, 
and IL-1β was determined by immunohistochemistry [IHC], as pre-
viously described.17 For that purpose, DAKO-labelled streptavidin 
biotin [LSAB] + system peroxidase [DAKO Corporation, Carpinteria, 
CA, USA] kit, anti-mouse Gal-3 (ab7278 [9C4], 1:100; Abcam Inc., 
Cambridge, MA, USA), anti-mouse CD68 (ab49777 [514H12] 1:40; 
Abcam Inc., Cambridge, MA, USA), and anti-rabbit IL-1β [ab9722 
1:100; Abcam Inc., Cambridge, MA, USA] antibodies were used. The 
counting was performed under standard light microscope. Expression 
of Gal-3, CD68, and IL-1β in colon tissue for each section was counted 
by using 400x magnification in five selected areas with highest density 
infiltration. The number of positive inflammatory cells in mucosa is 
presented as percentage. The average percentage of positive cells per 
high-power field was determined by two independent pathologists 
without previous information about the patient’s clinical data.
2.3. In vitro stimulation of peripheral blood 
mononuclear cells
Peripheral blood mononuclear cells [PBMNCs] were prepared as 
previously described.9 PBMNCs were isolated from UC patients and 
non-UC controls, plated in a 24-well plate [1 × 106 cells per well] and 
primed with 10 ng/ml LPS [lipopolysaccharides from Escherichia 
coli L2880, Sigma Aldrich] in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum, 2 mmol/l L-glutamine, 
1 mmol/l penicillin-streptomycin, and 1 mmol/l mixed non-essential 
amino acids [Sigma, USA] at 37°C in 5% CO2 in a fully humidified 
atmosphere for 48 h, as suggested.7
2.4. Flow cytometry analysis of PBMNCs
Expression of Gal-3 on PBMNCs was analysed by flow cytometry 
[FACS], as described.1
2.5. Animals
Male, 6-8-week-old wild type [WT] and Gal-3-/- C57BL/6 mice 
[provided by Dr Daniel Hsu, University of California, Sacramento, 
CA] were used for the induction of DSS-induced colitis. Targeted 
disruption of mouse Gal-3 gene was performed in C57BL/6 embry-
onic stem cells and mice homozygous for the disrupted gene were 
obtained.18 Breeding pairs of Gal-3-/- and WT Gal-3+/+ C57BL/6 mice 
of the same substrain were maintained in animal facilities of the 
Faculty of Medical Sciences, University of Kragujevac, Serbia. All 
animals received humane care and all experiments were approved 
by and conducted in accordance with, the Guidelines of the Animal 
Ethics Committee of the Faculty of Medical Sciences, University of 
Kragujevac, Serbia. Mice were housed in a temperature-controlled 
environment with a 12-h light-dark cycle and were administered 
standard laboratory chow and water ad libitum.
2.6. Induction of acute colitis
DSS [3%, molecular weight 40 kDa; TdB Consultancy, Uppsala, 
Sweden] was given to mice in place of normal drinking water for up 
to 7 days.19 Control mice had access to DSS-free water.
2.7. Pharmacological inhibition of Gal-3
WT mice were treated with inhibitor of galectin-3 [GM-CT-01; 
100 μg on Days 0, 2, 4, and 6, intraperitoneally], kindly provided by 
Dr Anatole Klyosov.20
2.8. Assessment of the severity of colitis
Disease Activity Index [DAI] was used to assess the clinical signs of 
colitis.21 Body weight measurements, analysis of stool consistency, 
and faecal occult blood tests were performed daily.21
2.9. Histology
For histological analysis, colons were removed from euthanised mice, 
rinsed with phosphate buffer solution [PBS], and cut longitudinally 
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before being rolled into ‘Swiss roll’, as previously described.22 Swiss-
rolled colons were fixed in formalin, embedded in paraffin, and 5-μm 
sections were stained with haematoxylin-eosin [H&E], and exam-
ined in a blinded manner by a pathologist. Sections were analysed 
for damage to epithelium including damage to crypts, submucosal 
oedema, haemorrhage, and infiltration by immune cells. The histol-
ogy score for each mouse was calculated as the sum of ‘Infiltration’ 
and ‘Damage of Epithelium’ sub-scores, as previously described.23
2.10. Measurement of cytokines in serum of DSS-
treated animals
The commercial enzyme-linked immunosorbent assay [ELISA] sets 
[R&D Systems, Minneapolis, MN] were used to determine the con-
centration of IL-1β, IL-6, TNF-α, transforming growth factor beta 
[TGF-β], and IL-10, according to the manufacturer’s instructions.
2.11. Expression of Gal-3, IL-1β, and NLRP3 in  
DSS-injured colons
The expression of Gal-3, IL-1β, and NLRP3 was assessed using 
immunostaining, as described.17 Mouse intestinal sections were 
routinely fixed in 4% buffered formaldehyde, dehydrated through 
graded alcohols, cleared in xylene, and subsequently embedded 
in paraffin. The paraffin-embedded tissue samples were sectioned 
at 4–5 μm and tissue sections deparaffinised by two washes in 
xylene for 10 min, and rehydrated in series of 100%, 96%, 70%, 
and 50% alcohol solutions. Immunohistochemical staining was 
performed by the streptavidin-biotin method. Briefly, sections 
were incubated with 3% hydrogen peroxide to block endogenous 
peroxidase activity and then microwaved for 20 min in 10 mmol/l 
sodium citrate [pH 6.0]. The sections were incubated with rabbit 
polyclonal antibodies against Gal-3 [1:100 dilution; ab53082], 
IL-1β [1:50 dilution; ab9722], and NLRP3 [1:100 dilution; 
ab91525] for 60 min. After the incubation with primary antibod-
ies, biotinylated secondary antibodies were applied, followed 
by detection using the AEC [rabbit-specific HRP-AEC detection 
IHC kit, ab94361] method. AEC [3-amino-9-ethylcarbazole] was 
used as the chromogen. Counterstaining was performed with 
haematoxylin.
2.12. Real time reverse transcriptase polymerase 
chain reation analysis
Messenger RNA [mRNA] analysis for NLRP3 and IL-1β was per-
formed as described.24 In order to prevent the inhibitory effect of 
DSS on the reverse transcriptase activity, we used the established 
protocol.25 Total RNA was extracted using TRIZOL reagent 
[Invitrogen, Paisley, UK] according to the manufacturer’s instruc-
tions. Approximately 1 mg of RNA was used in the reverse tran-
scription reaction using M-MuLV reverse trascriptase and random 
hexamers [Fermentas, Vilnus, Lithuania] according to the manu-
facturer’s instructions. Real-time reverse transcriptase polymerase 
chain reaction [RT-PCR] was performed in a 96-well reaction plate 
[MicroAmp Optical, Foster City, CA] in a Realplex Mastercycler 
[Eppendorf, Hamburg, Germany]. The reactions were prepared 
according to the standard protocol for one-step QuantiTect SYBR 
Green RT-PCR [Applied Biosystems, Warrington, UK], using com-
mercially available primers for Gal-3, NLRP3, and IL-1β. For the 
detection of IL-10 and TGF-β, TaqMan Master Mix and the fol-
lowing TaqMan primers and probes from Life Technologies 
[Carlsbad, CA] were used: IL-10 [Mm00439614_m1] and TGF-β 
[Mm01178820_m1].
2.13. Flow cytometry analysis of colon 
infiltrating cells
Isolation of immune cells from lamina propria and flow cytometry 
analysis were conducted as previously described.26 Briefly, each colon 
was dissected away from caecum. The colons were cut in pieces 3 cm 
long and then cut longitudinally, so that 3 x 3–cm flaps of colonic 
tissue were made. The flaps were placed in a 50-ml conical tube 
and washed three to five times with 30 ml cold HBSS, calcium and 
magnesium free. After decanting the supernatant, the pieces were 
incubated in 20 ml HBSS/EDTA for 30 min in a 37°C water bath. 
Each tube was shaken regularly during the incubation to ensure that 
epithelial cells were disrupted from the mucosa. The pieces were 
sedimented and the supernatant was decanted. The remaining EDTA 
were washed out with 40 ml HBSS, calcium and magnesium free. 
The fragments of colonic tissue were placed in a 10-cm Petri dish 
and cut into smaller pieces with a scalpel. The pieces were aspirated 
with a pipette, transferred to a fresh 50-ml conical tube and filled 
to 20 ml with Dulbecco’s Modified Eagle Medium [DMEM] sup-
plemented with 10% fetal bovine serum [FBS]. Then, 1 ml of 4000 
Mandl units [3 x 106 Wünsch units]/ml collagenase D and 200 µl of 
1 mg/ml DNase were added to the tube and incubated for 1 h in a 37° 
C water bath. The supernatant was filtered through a 100-µm nylon 
cell strainer into a clean 50-ml conical tube. Cold HBSS, calcium and 
magnesium free, was added to 50 ml. Cells were pelleted by centri-
fuging 10 min at 450 g, at 4°C. The pellet was disrupted and cells 
were re-suspended in 50 ml HBSS, calcium and magnesium free, and 
filtered through a 40-µm nylon cell strainer into a clean 50-ml coni-
cal tube. Cells were again pelleted by centrifuging 10 min at 450g, at 
4°C. The pellet was disrupted and cells were re-suspended in 20 ml 
of 30% Percoll. Then, the cell suspension was carefully layered over 
25 ml of 70% Percoll in a 50-ml conical tube and centrifuged for 
20 min at 1100 x g, room temperature, with as low an acceleration 
rate as possible and with the brake off. Clumping of cells was pre-
vented by the addition of 1 mM EDTA to the solution. Epithelial 
cells floated on the 30% Percoll layer, and immune cells were found 
between the 30% and 70% layers. Debris and dead cells were pel-
leted at the bottom of the conical tube.
Flow cytometry followed routine procedures by using 1 x 
106 cells per sample, and were incubated with anti-mouse F4/80, 
CD11b, CD206, I-A, CD11c, CD80, CD8, CD45, CD117, FcεRI, 
CD3, and Gal-3 conjugated with fluorescein isothiocyanate [FITC; 
BD Biosciences, Franklin Lakes, NJ], phycoerythrin [PE; BD 
Biosciences], peridinin chlorophyll protein [BD Biosciences], or 
allophycocyanin [APC; BD Biosciences]. For the intracellular stain-
ing, cells were previously stimulated with phorbol myristate acetate 
[PMA] and ionomycin for 4 h at 37°C with the addition of 1 μg/ml 
Golgi plug. Following extracellular staining, cells were fixed, per-
meabilised, and stained for IL-6, IL-12, IL-1β, IL-10, and TNF-α 
conjugated with fluorescein isothiocyanate [FITC; BD Biosciences, 
Franklin Lakes, NJ], phycoerythrin [PE; BD Biosciences], peridinin 
chlorophyll protein [BD Biosciences], or allophycocyanin [APC; 
BD Biosciences]. Flow cytometric analysis was conducted on a BD 
Biosciences FACSCalibur and analysed by using the WinMDI soft-
ware analysis program.
2.14. Isolation and in vitro stimulation of peritoneal 
macrophages
Macrophages were isolated from the peritoneal cavity of untreated, 
healthy WT and Gal3-/- mice, plated at a density of 106 cells/well, 
primed with 10 ng/ml LPS for 2 h, and incubated with 3% DSS for 
24 h, as described.27 The levels of TNF-α and IL-1β were determined 
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in macrophages by flow cytometry and in cell culture supernatants 
by ELISA sets, according to manufacturer’s recommendations.
2.15. Adoptive transfer of peritoneal macrophages
Peritoneal macrophages isolated from untreated, healthy WT and 
Gal3-/- mice, were intravenously transferred [1 x 106] into Gal3-/- 
recipients at Days -1 and +1 of DSS treatment, as suggested.28
2.16. In vivo depletion of macrophages
Clodronate-containing liposomes [standard macrophage depletion 
kit; Encapsula NanoSciences LLC] were intraperitoneally [i.p.] 
injected 4 days before onset of DSS colitis, to ensure depletion of 
resident macrophages, and every 2 days of DSS treatment, to deplete 
new infiltrating macrophages.29
2.17. Adoptive transfer of peritoneal neutrophils
Neutrophils were harvested from the peritoneum of healthy WT 
and Gal3-/- mice, 8 h after i.p. injection of 3% thioglycollate, 30 puri-
fied by magnetic cell sorting, and transferred [i.p. 2 x 106 cells per 
mouse] into Gal3-/- recipients at Day 4 of DSS treatment, as previ-
ously described.31
2.18. Isolation of DCs and adoptive transfer of DCs
DCs were isolated from spleen of healthy WT and Gal-3-/- mice by mag-
netic cell sorting. Single-cell suspensions of mononuclear cells derived 
from the spleen were labelled with CD11c MicroBeads [Miltenyi Biotec]. 
The labelled cells were subsequently positively selected using MACS 
Column [Miltenyi Biotec] and MACS Separator [Miltenyi Biotec]. 
Isolated DCs were then used in the adoptive transfer experiments.
For adoptive transfer-based experiments, healthy WT and Gal-3-/-  
DCs [2 x 1 05 cells per mouse] were transferred i.p. into DSS-treated 
Gal-3-/- recipients on the fifth day of DSS administration, as suggested.32
2.19. In vivo activation of NKT cells
In order to test the effect of genetic deletion of Gal-3 on the protec-
tive function of NKT cells in DSS-induced colitis,33 a specific and 
potent activator of NKT cells, α-galactoceramide [α-GalCer], was 
injected [100 μg/kg body weight, i.p. every day of the experiment] in 
DSS-treated WT and Gal-3-/- mice.34
2.20. Statistics
Data were expressed as the mean ± standard error of the mean [SEM] 
for each group. Results were analysed by Student’s t test. Pearson’s 
or Spearman’s correlation coefficient was used to test the correla-
tions between two variables. Statistical analyses were performed 
using SPSS 19.0 for Windows software [SPSS Inc., Chicago, IL]. The 
difference was considered significant when p < 0.05.
3. Results
3.1. Gal-3 is highly expressed in the colons of 
patients with ulcerative colitis
Compared with non UC controls, Gal-3 was highly expressed in the 
colons of patients suffering from UC [Figure 1A]. In addition, the expres-
sion of Gal-3 correlated with clinical and histological scores [Figure 1B].
Immunohistochemical staining revealed strong association 
between expression of Gal-3, CD68, and IL-1β, indicating the impor-
tance of Gal-3 for macrophage activation in the colon [Figure 1A]. 
Only few CD68+ cells were noticed in the lamina propria of non-UC 
controls and Gal-3 was mainly expressed on crypt epithelium. In 
contrast, there was intense Gal-3 staining both in the epithelium and 
in the lamina propria of UC patients [Figure 1A]. Strong expression 
of CD68 and Gal-3 noticed on the majority of lamina propria-infil-
trating mononuclear cells of UC patients suggests an involvement of 
Gal-3 in macrophage-dependent colonic inflammation.
In vitro LPS-stimulated PBMNCs obtained from UC patients 
produced significantly more Gal-3 than healthy controls [Figure 1C], 
and the percentage of PBMNCs that express CD14 and Gal-3 was 
significantly higher in UC patients, indicating the importance of 
Gal-3 for LPS-dependent activation of macrophages [Figure 1C].
3.2. Expression of Gal-3 in the colon tissue is 
associated with a progression of DSS-induced 
colitis and infiltration of immune cells in mice
There was an increased expression of Gal-3 in the colon of C57BL/6 
mice during the progression of DSS-induced colitis [Figure 2A, B]. The 
expression of Gal-3 correlated with disease activity index and histologi-
cal score and was associated with the influx of immune cells in diseased 
colon tissue [Figure 2C]. Gal-3 was expressed on lamina propria-infil-
trating F4/80+ macrophages, CD11c+ DCs, as well as CD45+Ly6G+ 
neutrophils that were present in significantly higher numbers in colons 
of DSS-treated mice compared with control animals [Figure 2D].
3.3. Genetic deletion of Gal-3 attenuates  
DSS- induced colitis
All of DSS-treated WT mice developed severe colitis with similar clini-
cal symptoms. The presence of blood in the faeces was detected 1 or 
2 days after the start of DSS treatment, whereas gross bleeding and 
diarrhoea were observed from Day 4. Body weight loss [> 5%] became 
prominent after 4 days of DSS treatment. The DAI score, body weight 
loss, and colon shortening were significantly lower in DSS-treated Gal-
3-/- mice when compared with WT DSS-treated animals [Figure 3A-D].
Histological analysis of WT mice revealed that 7  days of DSS 
treatment caused severe inflammation and an almost complete ulcer-
ation of colons. Severe inflammation was manifested by significant 
epithelial cell damage, oedema, ulceration, extensive crypt drop-out 
and massive infiltration of immune cells [Figure 3E]. In contrast, the 
colon architecture in similarly treated Gal-3-/- mice appeared rela-
tively normal, showing only mild evidence of crypt distortion, wid-
ening, and inflammation [Figure 3E].
3.4. DSS-treated Gal-3-/- mice have lower levels 
of pro-inflammatory cytokines IL-1β and TNF-α in 
serum and colon tissue
Level of pro-inflammatory cytokines [IL-1β and TNF-α] were sig-
nificantly lower in sera and colons [IL-1β, TNF-α, and IL-6] of 
DSS-treated Gal-3-/- mice when compared with WT DSS-treated 
mice [Figure 3F]. Conversely, there were significantly higher levels 
of TGF-β and anti-inflammatory IL-10 in sera and higher expression 
of IL-10 mRNA in colons of Gal-3-/- mice when compared with WT 
DSS-treated mice [Figure 3F].
3.5. Genetic deletion of Gal-3 results in markedly 
reduced number of macrophages, inflammatory 
DCs, and neutrophils in colons of DSS-treated mice
There were significantly lower numbers of colon-infiltrating 
immune cells in colons of DSS-treated Gal-3-/- mice when compared 
with similarly treated WT animals [Figure  4A]. Flow cytometry 
analysis showed that the total numbers of colonic macrophages 
[F4/80+CD11b+SiglecF-], inflammatory DCs [CD11c+CD11b+], 
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TNF-α producing, I-A-and CD80-expressing DCs, as well as TNF-α 
and IL-1β producing neutrophils [CD45+Ly6G+CD11c-] were lower 
in colons of DSS-treated Gal-3-/- mice [Figure 4B-D, p< 0.001].
The percentage of regulatory DCs [CD11c+CD8+] and IL-10 
producing DCs [p < 0.001] as well as the total number of protec-
tive NKT cells [CD3+NK1.1+] were significantly higher in colons of 
DSS-treated Gal-3-/- mice [p < 0.05] [Figure 5A]. There was no sig-
nificant difference in total number of NK cells [NK1.1+CD3-], mast 
cells [CD117+FcERI+], or eosinophils [CD45+SinglecF+] between 
the experimental groups [Figure 5B].
3.6. Genetic deletion of Gal-3 did not directly affect 
function of neutrophils, DCs, or NKT cells
Although it is well known that Gal-3 has an important role in neu-
trophil function,6 adoptive transfer of peritoneal neutrophils isolated 
from either WT or Gal-3-/- mice did not enhance severity of DSS-
induced colitis in Gal-3-/- animals [see Supplementary Figure 1, avail-
able as Supplementary data at ECCO-JCC online].
Since we recently showed that Gal-3 regulates the cross-talk between 
DCs and NKT cells in the liver, 17 and we noticed significant difference 
in the number of DCs and NKT cells in colons of DSS-treated WT and 
Gal-3-/- mice [Figures 4C, 5A], we analysed whether genetic deletion of 
Gal-3 affects the function of colonic DCs and NKT cells.
Adoptive transfer of both WT and Gal-3-/- DCs did not signifi-
cantly aggravate severity of DSS-induced colitis in Gal-3-/- mice [see 
Supplementary Figure  2, available as Supplementary data at ECCO-
JCC online]. Injection of α-GalCer, specific and potent activator of NKT 
cells, significantly attenuated DSS-induced colitis in both WT and Gal-3-
/- mice, as evaluated by clinical and histology scores [see Supplementary 
Figure 3A-D, available as Supplementary data at ECCO-JCC online ]. In 
addition, administration of α-GalCer significantly elevated the percent-
age of protective IL-10 producing NKT in colons of both DSS-treated 
WT and Gal-3-/- mice [see Supplementary Figure 3E].
Thus, it appears that α-GalCer induced NKT cells have a protec-
tive effect in DSS-induced colitis, both in WT and in Gal-3-/- mice. 
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α-GalCer treated animals remains statistically significant in both 
WT and Gal-3-/- mice [see Supplementary Figure 3].
3.7. Gal-3 deletion attenuated production of pro-
inflammatory cytokines in macrophages and 
favoured their alternative activation
Intracellular staining showed that there were significantly 
higher numbers of F4/80+CD206+ and IL-10 producing alter-
natively activated M2 macrophages and significantly reduced 
numbers of IL-1β-, IL-12 and IL-6 producing inflammatory 
F4/80+CD11b+I-A+ macrophages in colons of DSS-treated 
Gal-3-/- mice compared with similarly treated WT animals 
[Figure 6A].
In order to establish the inherent capacity of WT and Gal-3-/- 
macrophages to respond to specific [DSS] and general [LPS] stimuli, 
macrophages were isolated from untreated, healthy WT and Gal-3-/- 
animals and in vitro stimulated by LPS and DSS. In vitro LPS- and DSS-
stimulated peritoneal macrophages isolated from untreated Gal-3-/- mice 
produced lower amounts of TNF-α and IL-1β when compared with 
peritoneal macrophages isolated from healthy WT animals [Figure 6B].
3.8. Gal-3 deletion attenuates macrophage capacity 
to induce colon damage
In order to determine whether the difference in phenotype and func-
tion of WT and Gal-3-/- macrophages is crucial for attenuated DSS-
induced colitis in Gal-3-/- mice, adoptive transfer experiments were 
0
1
2
to
ta
l n
um
be
r 
of
 c
el
ls
 ×
 1
06
ce
lls
 ×
 1
05
in lamina propria of colon tissue
3
4
5
6
7
8
9
0
1
2
ce
lls
 ×
 1
05
CD11c+ I-A+ 
3
4
5
6
7
8
9
0
1
2ce
lls
 ×
 1
05
CD11c+ CD80+ 
5
3
4
0
0,2
0,4ce
lls
 ×
 1
05
CD45+CD11c-Ly6G+ TNF-α+ CD45+CD11c-Ly6G+ IL-1-β+
1
0,6
0,8
0
0,2
0,4ce
lls
 ×
 1
05
1,2
0,8
0,6
1
0
1
2
ce
lls
 ×
 1
05
CD45+Ly6G+CD11c-
3
0
1
2
F4/80+CD11b+ SiglecF-
3
4
5
6
7
8
9
10
ce
lls
 ×
 1
05
0
1
2
CD11c+DCs TNF-α+
3
4
WT control
CD11b
F4
/8
0
SiglecF
WT Gal-3-/-
26.15% 14.18%
8%
SS
C
-H
FL2-HFL2-H 10000
FL3-H 10000 10000
10000
F1.192
10
24
FL
1-
H
FL2-H
10
00
0
FL
1-
H
10
00
0
SS
C
-H
10
24 11%
Gal-3-/- control
Gal-3-/- + DSS
WT + DSS
5
6
7
8
9
10
ce
lls
 ×
 1
05
0
1
2
CD11c+ CD11b+
3
4
5
6
7
A
*
**
**
**
** **
** **
**
B
C
D
Figure 4. Genetic deletion of Galectin-3 [Gal-3] results in markedly reduced number of inflammatory cells in colons of dextran sulphate sodium [DSS]-treated 
mice. The total number of immune cells in colons of DSS-treated Gal-3-/- mice was higher when compared with similarly treated wild type [WT] animals [A]. The 
total number of F4/80+CD11b+SiglecF- macrophages is shown as well as representative flow cytometry dot plots [B]. Inflammatory CD11c+CD11b+ DCs, tumour 
necrosis factor alpha [TNF-α] producing dendritic cells [DCs], as well as DCs expressing I-A and co-stimulatory CD80, were significantly lower in colons of Gal-3-/- 
DSS treated mice [C]. The total numbers of TNF-α and interkeukin-1 beta [IL-1β] producing CD45+Ly6G+CD11c- neutrophils were lower in colons of Gal-3-/- DSS 
treated mice [D]. Values are mean ± standard error of the mean [SEM] [n = 10 per group]. *p < 0.05, **p < 0.001.
The Pro-inflammatory Role of Gal-3 in Acute Colitis 7
 by guest on February 26, 2016
http://ecco-jcc.oxfordjournals.org/
D
ow
nloaded from
 
0 0 0
1
2
3
4
5
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1,8
2
2
4
6
8
10
12
A
ce
lls
 ×
 1
05
F4/80+ CD206+
F4/80+ IL-12+
TNF-α IL-β
F4/80+ IL-6+ F4/80+ I-A+
F4/80+ IL-10+ F4/80+ IL-1β+
ce
lls
 ×
 1
05
ce
lls
 ×
 1
05
ce
lls
 ×
 1
05
ce
lls
 ×
 1
05
ce
lls
 ×
 1
05
pg
/m
l
pg
/m
l
B
14
0
2
4
6
8
10
12
20
14
16
18
0
100
200
300
400
500
900
600
700
800
0
**
*
*
* *
**
**
1
2
3
5
4
0
Control DSS-
treated
LPS-
treated
LPS+DSS
treated
Control DSS-
treated
LPS-
treated
LPS+DSS
treated
200
100
300
400
600
500
0
1
2
3
5
6
7
8
4
WT control
Gal-3-/- control
Gal-3-/- + DSS
WT + DSS
Gal-3-/- + DSS
WT + DSS
Figure 6. Galectin-3 [Gal-3] deletion favoured macrophages alternative activation. The number of F4/80+CD206+ and interleukin-10 [IL-10] producing alternatively 
activated M2 macrophages [A]. After 7  days of dextran sulphate sodium [DSS] treatment there was significantly reduced number of IL-1β-, IL-12 and IL-6 
producing inflammatory F4/80+CD11b+I-A+ macrophages in colons of Gal-3-/- mice compared with wild type [WT] animals [A]. In vitro lipopolysaccharide 
[LPS]- and DSS-stimulated peritoneal macrophages isolated from healthy Gal-3-/- mice produce lower amounts of tumour necrosis factor alpha [TNF-α] and 
interleukin-1 beta [IL-1β] when compared with peritoneal macrophages isolated from healthy WT animals [B]. Values are mean ± standard error of the mean 
[SEM] [n = 10 per group]. *p < 0.05, **p < 0.001.
0
1
2
3
4
5
pe
rc
en
ta
ge
 (
%
)
6
7
8
A
B
** ** *
0
1
2
3
4
5
pe
rc
en
ta
ge
 (
%
)
6
7
8
0
1
2
3
4
5
ce
lls
 ×
 1
05
ce
lls
 ×
 1
05
ce
lls
 ×
 1
05
CD11c+CD8+ CD11c+IL-10+
6
7
8
9
10
0
1
2
3
4
5
pe
rc
en
ta
ge6
7
8
0
1
2
3
0
1
2
3
4
5
CD3+NK1.1+NKT cells
Nk1.1 NK cells FcεR1+CD117+ mast cells CD45+ SinglecF+ eosinophils
WT control
Gal-3-/- control
Gal-3-/- + DSS
WT + DSS
Figure 5. Genetic deletion of Galectin-3 [Gal-3] enhances number of regulatory dendritic cells [DCs] in colons of dextran sulphate sodium [DSS]-treated mice. 
The percentage of regulatory DCs [CD11c+CD8+] and interleukin-10 [IL-10] producing DCs [p < 0.001], as well as the total number of protective CD3+NK1.1+NKT 
cells, was significantly higher in colons of DSS-treated Gal-3-/- mice [A]. The number of NK1.1+CD3- NK cells, CD117+FcERI+ mast cells and percentage of 
CD45+SinglecF+ eosinophils is shown [B]. Values are mean ± standard error of the mean [SEM] [n = 10 per group]. *p < 0.05, **p < 0.001.
8 B. Markovic et al.
 by guest on February 26, 2016
http://ecco-jcc.oxfordjournals.org/
D
ow
nloaded from
 
done. Adoptive transfer of WT macrophages significantly enhanced 
the severity of DSS-induced colitis in Gal-3-/- mice [Figure 7A-D], 
as evaluated by clinical and histological parameters. Adoptive 
transfer of WT macrophages in DSS-treated Gal-3-/- mice resulted 
in significant increase in DAI score, body weight loss, colon short-
ening, gross bleeding, and diarrhoea. As shown in Figure  7, the 
transfer of WT macrophages in comparison with Gal-3-/- mac-
rophages significantly enhanced disease activity index [Figure 7A]. 
This is the best illustrated in histological slides [Figure 7D] show-
ing massive destruction of crypts in Gal-3-/- mice injected with 
WT macrophages [lower panel] compared with almost normal 
colon architecture seen in mice injected with Gal-3-/- macrophages 
[upper panel], occurring in parallel with an emerging inflammatory 
response and elevated serum levels of pro-inflammatory cytokines 
IL-1β and TNF-α [Figure 7E].
3.9. Macrophage depletion diminished the 
differences in severity of DSS-induced colitis 
between WT and Gal-3-/- mice
In order to clarify whether macrophage depletion affects the differ-
ence between DSS-treated WT and Gal-3-/- mice, clodronate-con-
taining liposomes were initially injected intraperitoneally 4 days 
before DSS administration and continued every second day [0, 2, 
4, 6] of the protocol. Macrophage depletion significantly attenu-
ated DSS-induced colitis in WT as evaluated by clinical and histo-
logical scores. Most importantly, macrophage depletion diminished 
the differences between DSS-treated WT and Gal-3-/- mice. There 
were no significant differences in DAI score, body weight loss, 
or colon shortening between DSS-treated WT and Gal-3-/- mice 
after injection of clodronate-containing liposomes [Figure 8A-C]. 
Histological analysis confirmed these findings, showing no signifi-
cant differences in colon architecture between DSS-treated WT 
and Gal-3-/- mice that received clodronate-containing liposomes. 
All colons appeared relatively normal, showing only mild evidence 
of crypt distortion, widening, and inflammation [Figure 8D].
3.10. Gal-3 is important for activation of 
inflammasome and production of IL-1β in 
macrophages
Recently, the activation of NLRP3 inflammasome in macrophages 
was identified as a critical mechanism of intestinal inflammation in 
the DSS colitis model.27 Accordingly, we investigated whether genetic 
deletion of Gal-3 affects activation of NLRP3 inflammasome in 
colon-infiltrated macrophages.
A real-time RT-PCR analysis of colon tissue from Gal-3-/- and 
WT DSS-treated mice revealed significantly reduced expression of 
mRNA encoding NLRP3 and IL-1β in DSS-treated Gal-3-/- mice 
[Figure 9A]. Both NLRP3 and IL-1β were significantly less expressed 
in colon tissue samples of DSS-treated Gal-3-/- mice when compared 
with DSS-treated WT animals [Figure  9B-D C], as determined by 
immunohistochemistry.
Flow cytometry analysis of LPS- and DSS-activated peritoneal 
macrophages showed decreased expression of NLRP3 and IL-1β in 
Gal-3-/- cells [Figure 9E].
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3.11. Pharmacological inhibition of Gal-3 markedly 
attenuated DSS-induced colitis by reducing 
activation of inflammasome and production of IL-1β
In line with results obtained from Gal-3-/- mice, GM-CT-01 treat-
ment attenuated DSS-induced colitis, ameliorated diarrhoea and rec-
tal bleeding, and reduced the loss of body weight [Figure 10A]. These 
findings were confirmed by histological analysis. In DSS-treated mice 
that received inhibitor, the colonic mucosa showed slight pathologi-
cal changes including a reduced extent of colon damage and reduced 
infiltration of inflammatory cells. The structure of the crypt epithe-
lial cells remained intact, and the histopathological injury scores 
were significantly decreased [p < 0.001] when compared with DSS-
treated animals.
Similar to Gal-3-/- mice, activation of inflammasome and produc-
tion of IL-1β were attenuated in DSS+GM-CT-01 treated mice. The 
expression of NLPR3 and IL-1 β in colons as well as serum levels of 
pro-inflammatory cytokines [IL-1β and TNF-α] [Figure 10B-D] were 
significantly lower in DSS-treated mice after GM-CT-01 treatment, 
indicating the important role of Gal-3 for inflammasome activation 
in DSS-induced colitis.
Discussion
The acute DSS-induced colitis as a model is very popular in inflam-
matory bowel disease [IBD] research due to its rapidity, simplicity, 
reproducibility, and controllability and is usually used to elucidate 
molecular and cellular pathways involved in pathogenesis of acute 
colitis in humans. DSS has a toxic effect on epithelial cells, enabling 
invasion of intestinal bacteria into subepithelial tissue. During the 
induction phase of acute colitis, CD14/TLR4:LPS-dependent inter-
action between macrophages and bacteria that have passed through 
injured colonic epithelium, results in activation of NLRP3 inflam-
masome and production of pro-inflammatory IL-1β in macrophages, 
leading to the development of inflammation in colon tissue.12,27,35,36
However, it should be noted that acute DSS colitis has some limi-
tations.11 Unlike in human disease, T and B cells are not required for 
development of acute DSS-induced colonic inflammation, and this 
model is useful only when studying the contribution of the innate 
immune system to the development of intestinal inflammation.37
Since Gal-3 is involved in migration and function of macrophages, 
DCs, and neutrophils in inflamed tissues14,15, we used acute DSS coli-
tis to establish the precise role of Gal-3 in cellular and molecular 
processes that lead to the acute phase of colon inflammation.
Here we provide the first evidence that Gal-3 plays an impor-
tant pro-inflammatory role in the induction phase of acute colitis by 
promoting activation of NLRP3 inflammasome and production of 
IL-1β in macrophages. Our findings indicate that genetic deletion or 
pharmacological inhibition of Gal-3 significantly reduces activation 
of NLRP3 inflammasome and production of inflammatory IL-1β 
in macrophages, resulting in attenuated inflammation and colitis 
[Figures 9, 10]. We showed that adoptive transfer of peritoneal mac-
rophages isolated from WT healthy animals significantly elevated 
serum level of IL-1β, and enhanced severity of DSS-colitis in Gal-3-
/- mice, suggesting that Gal-3-/- macrophages have reduced capacity 
for IL-1β production and colon damage [Figure 7]. In vivo depletion 
of macrophages completely diminished the differences in DSS-colitis 
between WT and Gal-3-/- mice, further indicating the importance of 
Gal-3 for macrophage activation in acute colitis [Figure 8].
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We also found that LPS- and DSS-activated Gal-3-/- peritoneal 
macrophages showed decreased expression of NLRP3 and IL-1β 
compared with WT cells in vitro [Figure 9E] and in vivo [Figure 9A 
D]. In addition, pharmacological inhibition of Gal-3 markedly 
attenuated DSS-induced colitis by reducing activation of inflamma-
some and production of IL-1β [Figure  10], further indicating the 
importance of Gal-3 for activation of inflammasome in the induc-
tion phase of acute colitis. It is well known that Gal-3 plays an 
important role in macrophage polarisation and function.1 Gal-3 is 
secreted by activated macrophages at inflammation sites and plays 
an important role in inflammatory diseases caused by bacteria and 
their products, such as LPS.38 Monomeric Gal-3 interacts with LPS 
glycans from LPS aggregates via its C-terminal domain. LPS:Gal-3 
interactions induce Gal-3 oligomerisation which promotes the dis-
solution of LPS aggregates, stabilizes LPS monomers, and enhances 
the LPS interaction with CD14 leading to increased activation of 
phagocytes.38 Accordingly, we assume that, during the induction 
phase of acute colitis, LPS released from intestinal bacteria induce 
Gal-3 oligomerisation and CD14 clustering on the macrophages, 
resulting in enhanced CD14/TLR4:LPS-dependent activation of 
NLRP3 inflammasome and production of IL-1β in macrophages [see 
Supplementary Figure 4, available as Supplementary data at ECCO-
JCC online]. These results are in line with our previous findings.3,39 
In an animal model of liver steatosis, we noticed attenuated inflam-
mation, reduced number of macrophages, and decreased expression 
of NLRP3 inflammasome and IL-1β in the livers of Gal-3 deficient 
mice.39 In an animal model of type 1 diabetes, we noticed that mac-
rophages of Gal-3-/- mice produce lower amounts of inflammatory 
cytokines and are less effective in intracellular and extracellular kill-
ing compared with WT mice.3
In addition to reduced activation of inflammasome, Gal-3 dele-
tion favoured an alternative activation of macrophages in vitro 
0
50
100
150
200
250
300A
C D
B
WT control WT + DSS WT control
E
NLRP3
E
xp
re
ss
io
n
Pe
rc
en
ta
ge
 o
f 
ex
pr
es
si
on
IL-1β
F4/80+NLRP3+ F4/80+IL-1β+
*
**
**
**
*
0
Control DSS-treated LPS-treated LPS+DSS treated
2
4
6
8
10
12
14
16
pe
rc
en
ta
ge
Gal-3-/- control
Gal-3-/- control Gal-3-/- + DSS Gal-3-/- control Gal-3-/- + DSS
WT + DSS
WT control
Gal-3-/- + DSS
WT + DSS
Gal-3-/- + DSS
WT + DSS
WT + DSS
Gal-3-/- + DSS
0
NLRP3 IL-1β
5
10
15
20
25
**
0
Control DSS-treated LPS-treated LPS+DSS treated
2
4
6
8
10
12
pe
rc
en
ta
ge
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when compared with DSS-treated wild type [WT] animals [B-D], as determined by immunohistochemistry. Peritoneal macrophages isolated from healthy 
WT and Gal-3-/- mice were treated with increasing concentrations of DSS in the absence or presence of lipopolysaccharide [LPS] priming. The total number of 
F4/80+NLRP3+ and F4/80+IL-1β+ macrophages was determined by flow cytometry [E]. Values are mean ± standard error of the mean [SEM] [n = 10 per group]. 
*p < 0.05, **p < 0.001.
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and in vivo [Figure 6A]. These results are in line with our previous 
findings obtained in an animal model of acute hepatitis,1 where we 
found significantly increased numbers of IL-10 producing alterna-
tively activated, M2-polarised macrophages in the livers of Gal-3 
deficient mice and in mice pre-treated with selective inhibitor 
of Gal-3.
By producing inflammatory cytokines and chemokines, DSS-
activated macrophages induce migration of neutrophils, DCs, NK, 
and NKT cells, mast cells, and eosinophils in the colon, leading to 
progression of acute colitis.12
Targeted disruption of Gal-3 resulted in significantly lower num-
bers of IL-1β, IL-6 and IL-12 producing macrophages [Figure 6A], 
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Figure 10. Pharmacological inhibition of Galectin-3 [Gal-3] markedly attenuated dextran sulphate sodium [DSS]-induced colitis. Daily weight measurements 
were obtained for each group of mice. Assessment of daily disease activity measurements, encompassing weight, stool consistency, and presence of blood, 
was performed for each group of mice [A]. Colon length measurements for each mouse was taken following harvest at Day 7 post DSS and are displayed. 
Representative histological images are shown. Interleukin-1 beta [IL-1β] and tumour necrosis factor alpha [TNF-α] were determined in the supernatant by 
enzyme-linked immunosorbent assay [ELISA] [B]. Percentage of expression of NOD-like receptor family, pyrin domain containing 3 [NLRP3] and IL-1β in colon 
tissue [C]. Expression of NLRP3 and IL-1β in colon tissue of healthy wild type [WT] DSS-treated and WT DSS+GM-CT-01-treated mice are demonstrated [D]. Values 
are mean ± standard error of the mean [SEM] [n = 10 per group]. * p < 0.05, **p < 0.001.
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which correlated with significantly reduced numbers of colon-infil-
trating inflammatory DCs and neutrophils, whereas the frequency 
and absolute number of eosinophils, NK, and mast cells were not 
affected by Gal-3 deletion [Figure 5B].
Gal-3 is important for the migration, adhesion, and maturation of 
mouse DCs.15 Accordingly, there were significantly lower numbers of 
inflammatory DCs in colons of DSS-treated Gal-3-/- mice [Figure 4C]. 
In pathogenesis of both human and DSS-induced colitis, neutrophils 
play an important role in phagocytosis of intestinal bacteria passing 
through the injured colonic epithelium.40 Activated neutrophils are a 
major source of inflammatory cytokines [TNF-α, IL-1β, and IL-6] that 
induce intestinal injury and inflammation.41 Gal-3 serves as a chemo-
attractant for neutrophils and plays an important role in phagocyto-
sis.6 Gal-3 increases phagocytic activity of neutrophils and enhances 
the LPS-mediated activation of neutrophils. In line with these obser-
vations, we noticed significantly lower numbers of TNF-α and IL-1β 
producing neutrophils in colons of DSS-treated Gal-3-/- mice, that cor-
related with attenuated colitis noticed in these animals [Figure 4D]. 
However, neither adoptive transfer of WT DCs nor WT neutrophils, 
isolated from healthy animals, significantly altered the differences in 
DSS-colitis between WT and Gal-3 deficient mice, suggesting that the 
reduced number of these cells in colons of DSS-treated Gal3-/- mice was 
only a consequence of attenuated inflammation caused by reduced 
activation of Gal-3-/- macrophages in the induction phase of colitis.
It is well known that activation of NKT cells by α-GalCer provides 
protection against colitis in mice, particularly in an IL-10 dependent 
manner.34 Here we found significantly higher numbers of protective 
IL-10 producing NKT cells in colons of DSS-treated Gal3-/- mice. 
Although administration of α-GalCer managed to significantly reduce 
colitis and increased total cell numbers of IL-10 producing NKT 
cells in colons of DSS-treated mice, injection of α-GalCer did not sig-
nificantly change the difference in disease progression between DSS-
treated WT and Gal-3-/- animals, suggesting that genetic deletion of 
Gal-3 did not directly affect function of NKT cells [see Supplementary 
Figure 3].
The results obtained in DSS-induced colitis correlate with data 
obtained from patients with UC. Gal-3 was significantly higher in the 
colons and sera of patients suffering from UC compared with non-
UC controls, and there was a strong correlation between expression 
of Gal-3, IL-1β, and macrophage lineage marker CD68 [Figure 1] in 
colons of UC patients. In addition, in vitro LPS-stimulated PBMCs 
obtained from UC patients produce significantly more Gal-3 then 
healthy controls [Figure 1C], and the percentage of PBMNCs that 
express CD14 and Gal-3 was significantly higher in UC patients, 
indicating the importance of Gal-3 for LPS-dependent activation of 
macrophages [Figure 1C].
In conclusion, we propose that Gal-3 plays an important pro-
inflammatory role in the induction phase of colitis by promoting 
the activation of NLRP3 inflammasome and production of IL-1β in 
macrophages. Gal-3 may serve as a potential target for the develop-
ment of novel therapeutics for patients with UC.
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